Dopamine, immunity, and disease
B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - Elsevier
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …
regulating many processes including reward, movement, and cognition. Dopamine also …
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)
M Pozzi, S Bertella, E Gatti, GGAM Peeters… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental
disorder affecting up to 5.3% of children and 2.5% of adults depending on the country …
disorder affecting up to 5.3% of children and 2.5% of adults depending on the country …
[图书][B] Adult ADHD: Diagnostic assessment and treatment
JJS Kooij - 2012 - books.google.com
Adult ADHD: Diagnostic Assessment and Treatment, Third Edition covers not only diagnostic
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
Vitamin–mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial
JJ Rucklidge, CM Frampton, B Gorman… - The British Journal of …, 2014 - cambridge.org
BackgroundThe role of nutrition in the treatment of attention-deficit hyperactivity disorder
(ADHD) is gaining international attention; however, treatments have generally focused only …
(ADHD) is gaining international attention; however, treatments have generally focused only …
[HTML][HTML] Alleviation of ADHD symptoms by non-invasive right prefrontal stimulation is correlated with EEG activity
U Alyagon, H Shahar, A Hadar, N Barnea-Ygael… - NeuroImage: Clinical, 2020 - Elsevier
Attention deficit hyperactivity disorder (ADHD) is a prevalent disorder with effective
pharmacological treatment that benefits most patients. However, about one-third fail to …
pharmacological treatment that benefits most patients. However, about one-third fail to …
Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis
RA Dezfouli, A Hosseinpour, S Ketabforoush… - Middle East Current …, 2024 - Springer
Introduction The aim of this study is to assess the effectiveness of serotonin-norepinephrine
reuptake inhibitors (SNRIs) in managing ADHD symptoms compared to placebo, stimulants …
reuptake inhibitors (SNRIs) in managing ADHD symptoms compared to placebo, stimulants …
Alternative pharmacological strategies for adult ADHD treatment: a systematic review
M Buoli, M Serati, W Cahn - Expert review of neurotherapeutics, 2016 - Taylor & Francis
ABSTRACT Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric
condition associated with high disability and frequent comorbidity. Current standard …
condition associated with high disability and frequent comorbidity. Current standard …
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
GE Brancati, A Magnesa, D Acierno… - Expert Review of …, 2024 - Taylor & Francis
Introduction Stimulants, including methylphenidate and amphetamines, are the first-line
pharmacological treatment of ADHD in adults. However, in patients who do not respond or …
pharmacological treatment of ADHD in adults. However, in patients who do not respond or …
ADHD with comorbid bipolar disorders: a systematic review of neurobiological, clinical and pharmacological aspects across the lifespan
F Mucci, MT Avella, D Marazziti - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Background: Attention deficit hyperactivity (ADHD) disorder is a neurodevelopmental
disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity …
disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity …
[HTML][HTML] Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children
S Mohammadzadeh, N Baghi, F Yousefi… - Korean journal of …, 2019 - ncbi.nlm.nih.gov
Background Attention deficit-hyperactivity disorder (ADHD) is one of the most common
chronic behavioral disorders in school-aged children. Purpose This study aimed to evaluate …
chronic behavioral disorders in school-aged children. Purpose This study aimed to evaluate …